Please login to the form below

Not currently logged in
Email:
Password:

cardiovascular

This page shows the latest cardiovascular news and features for those working in and with pharma, biotech and healthcare.

AZ taps Ionis for another drug, this time in NASH

AZ taps Ionis for another drug, this time in NASH

It’s the third time AZ has taken up an option on an Ionis drug under a 2015 alliance in the area of cardiovascular, metabolic and kidney disease, after earlier deals ... for cardiovascular drug AZD8233 and kidney disease candidate AZD2373.

Latest news

More from news
Approximately 32 fully matching, plus 877 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    the low commercial value placed on antibiotic drugs compared to more lucrative sectors such as cardiovascular disease and cancer.

  • Finding the patient voice Finding the patient voice

    rheumatoid arthritis, oncology, psychiatry, cardiovascular diseases, rare diseases etc.

  • The good, the bad and the ugly The good, the bad and the ugly

    Vertex’growth has been helped by obtaining reimbursement for its CFTR modulator, Orkambi, in Europe, ”says Pavan Kottamasu, analyst, cardiovascular and metabolic disorders. ... Merck &Co grew cardiovascular revenues by 130%, while GSK enjoyed a 214%

  • Reading human behaviour to create a medical future Reading human behaviour to create a medical future

    information cards were supplied to doctors that helped them understand the needs of a sector of cardiovascular patients.

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Imperial College London is ranked as the number one UK university in the respiratory, cardiovascular and gastroenterology fields, so it is sad and startling to discover such a huge disconnect between

More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 52 partially matching documents found.

Latest from PMHub

  • Patient Assistance Programme Evaluation for Cardiovascular Conditions

    Patient Assistance Programme Evaluation for Cardiovascular Conditions. Our client had launched a self-injection treatment for  cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in

  • ECHO Medical Communications

    ECHO Medical Communications. ECHO delivers dedicated medical communications specialising in the areas of endocrinology, cardiovascular disease, heart failure and obesity.

  • ECHO Medical Communications

    ECHO Medical Communications. ECHO delivers dedicated medical communications specialising in the areas of endocrinology, cardiovascular disease, heart failure and obesity.

  • emotive. launches new graduate program

    minor in cardiovascular, renal and respiratory biology.

  • Oculus Rift goes deeper with the Virtual Valve

    EuroPCR, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) is a leading congress in interventional medicine and provided the perfect backdrop for the launch of this ... Cardiovascular

More from PMHub
Approximately 1 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics